Photocure initiates enrolment into phase II trial of Cevira® for cervical HPV infection
First study to evaluate optimal dose of novel integrated drug-delivery device
21-Jun-2011 -
Photocure ASA has initiated patient enrolment in the first trial to evaluate the optimal dose and safety of Cevira, an integrated intravaginal drug-delivery device.The study is a randomized, placebo controlled dose finding study in patients with low to moderate grade cervical intraepithelial ...
Cevira
drug delivery
HPV
+1